PHARMACOVIGILANCE
Pharmacovigilance is the scientific field of monitoring the safety of medicines and the procedures to minimise the risk and improve the therapeutic effects of their use. To achieve this, it requires the collection and management of data related to the safety of medicines, detection of risk signals and evaluation of the data.
The purpose of pharmacovigilance is to ensure that the benefits of marketed medicines outweigh the risks. This is achieved by identifying new Adverse Drug Reactions (ADRs), promoting the safe use of medicines and preventing ADRs.
Information on the occurrence of adverse reactions comes either from Healthcare Professionals (Pharmacists, Doctors, Nurses) directly and/or through Marketing Authorization Holders (MAHs), or from patients themselves through Healthcare Professionals.
Adverse event reports can be submitted in a multitude of ways.
To Health Professionals
(Pharmacists, Doctors, Nurses)
To the holder of the Marketing Authorization:
- By phone at 2310909656
- By fax to 2310909656
- By e-mail info@crosspharma.gr
To the Department of Pharmacovigilance:
- By phone at 210-2838200
- By email pv@globaldevelopment.gr
To the National Organisation for Medicines, at the Adverse Reactions Department, by submitting the Yellow Card in the following ways:
- Electronic submission of the Yellow Card via the EOF website
http://www.eof.gr/web/guest/yellowgeneral Submit the yellow card by fax to 6549.585
- Send a printed copy of the Yellow Card by post, free of charge, to the Adverse Events
Department of the EOF (Mesogeion 284, Cholargos 15562) telephone number: 20.40.380ή 213.20.40.337